Clinical Trial

B.Brilliant Revelation Comparision Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is an observational study to evaluate the MAMMOMAT B.brilliant system. All diagnostic decisions are made by the treating radiologist based upon standard of care clinical imaging acquired on FDA approved devices
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-07-15; most recent amendment 2026-04-23.
Status change: Not Yet Recruiting → Recruiting 2025-12-03
Trial Details
NCT Number NCT07067788
Lead Sponsor University of Pennsylvania
Collaborators: Siemens Corporation, Corporate Technology
Conditions Breast Cancer Screening
Enrollment 100 participants
Start Date 2025-12-15
Primary Completion 2026-07-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-24